CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Open-market sale Chief Executive Officer sold 13,000 shares at an average $77.72 ($1,010,357)
- 4 Exercise or conversion Chief Scientific Officer acquired 4,137 shares (option exercise)
- 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $84.65 ($173,533)
- 4 Open-market sale Director sold 6,800 shares at $81.97 ($557,396)
- 4 Open-market buy Director bought 200 shares at $83.44 ($16,688)
- 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $82.33 ($164,661)
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $83.08 ($249,229)
- 4 Open-market sale Chief Executive Officer sold 13,000 shares at an average $81.09 ($1,054,218)
- 4 Exercise or conversion Director acquired 2,200 shares (option exercise)
- 4 Open-market sale Chief Commercial Officer sold 2,050 shares at $78.63 ($161,192)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $77.65 ($155,305)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at an average $76.04 ($228,128)
- 4 Open-market sale Chief Medical Officer sold 2,000 shares at an average $78.75 ($157,500)
- 4 Open-market sale Chief Executive Officer sold 13,000 shares at an average $78.75 ($1,023,756)
- 4/A Open-market buy 10% owner bought 851,154 shares at $67.00 ($57,027,318)
Page 22 of 38 · 758 filings